1. Executive Summary
1.1. Global Dermatophytic Onychomycosis Therapeutics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, 2018 - 2031
3.1. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Dermatophytic Onychomycosis Therapeutic Drugs
3.1.1.1.1. Oral
3.1.1.1.1.1. Rx
3.1.1.1.1.2. OTC
3.1.1.1.2. Topical
3.1.1.1.2.1. Rx
3.1.1.1.2.2. OTC
3.1.1.2. Dermatophytic Onychomycosis Therapeutic Lasers
3.1.1.2.1. C02 Ablative Lasers
3.1.1.2.2. Nd:YAG Lasers
3.1.1.2.3. Dual-wavelength near-infrared Lasers
3.1.1.3. Photodynamic Therapy
3.2. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Distal Subungual Onychomycosis
3.2.1.2. White Superficial Onychomycosis
3.2.1.3. Proximal Subungual Onychomycosis
3.2.1.4. Candidal Onychomycosis
3.2.1.5. Total Dystrophic Onychomycosis
3.3. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, by Gender, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Male
3.3.1.2. Female
3.4. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. 0-18 Years
3.4.1.2. 18-39 Years
3.4.1.3. 40-64 Years
3.4.1.4. 65 Years and Above
3.5. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. Institutional Sales
3.5.1.1.1. Hospitals
3.5.1.1.2. Dermatology Clinics
3.5.1.2. Retail Sales
3.5.1.2.1. Retail Pharmacies
3.5.1.2.2. Drug Stores
3.5.1.2.3. Mail Order Pharmacies & Online Sales
3.6. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.6.1. Key Highlights
3.6.1.1. North America
3.6.1.2. Europe
3.6.1.3. Asia Pacific
3.6.1.4. Latin America
3.6.1.5. Middle East & Africa
4. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, 2018 - 2031
4.1. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Dermatophytic Onychomycosis Therapeutic Drugs
4.1.1.1.1. Oral
4.1.1.1.1.1. Rx
4.1.1.1.1.2. OTC
4.1.1.1.2. Topical
4.1.1.1.2.1. Rx
4.1.1.1.2.2. OTC
4.1.1.2. Dermatophytic Onychomycosis Therapeutic Lasers
4.1.1.2.1. C02 Ablative Lasers
4.1.1.2.2. Nd:YAG Lasers
4.1.1.3. Dual-wavelength near-infrared Lasers
4.2. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Distal Subungual Onychomycosis
4.2.1.2. White Superficial Onychomycosis
4.2.1.3. Proximal Subungual Onychomycosis
4.2.1.4. Candidal Onychomycosis
4.2.1.5. Total Dystrophic Onychomycosis
4.3. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Gender, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Male
4.3.1.2. Female
4.4. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. 0-18 Years
4.4.1.2. 18-39 Years
4.4.1.3. 40-64 Years
4.4.1.4. 65 Years and Above
4.5. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. Institutional Sales
4.5.1.1.1. Hospitals
4.5.1.1.2. Dermatology Clinics
4.5.1.2. Retail Sales
4.5.1.2.1. Retail Pharmacies
4.5.1.2.2. Drug Stores
4.5.1.2.3. Mail Order Pharmacies & Online Sales
4.5.2. BPS Analysis/Market Attractiveness Analysis
4.6. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.6.1. Key Highlights
4.6.1.1. U.S. Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
4.6.1.2. U.S. Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
4.6.1.3. U.S. Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
4.6.1.4. U.S. Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
4.6.1.5. U.S. Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.6.1.6. Canada Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
4.6.1.7. Canada Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
4.6.1.8. Canada Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
4.6.1.9. Canada Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
4.6.1.10. Canada Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.6.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, 2018 - 2031
5.1. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Dermatophytic Onychomycosis Therapeutic Drugs
5.1.1.1.1. Oral
5.1.1.1.1.1. Rx
5.1.1.1.1.2. OTC
5.1.1.1.2. Topical
5.1.1.1.2.1. Rx
5.1.1.1.2.2. OTC
5.1.1.2. Dermatophytic Onychomycosis Therapeutic Lasers
5.1.1.2.1. C02 Ablative Lasers
5.1.1.2.2. Nd:YAG Lasers
5.1.1.3. Dual-wavelength near-infrared Lasers
5.2. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Distal Subungual Onychomycosis
5.2.1.2. White Superficial Onychomycosis
5.2.1.3. Proximal Subungual Onychomycosis
5.2.1.4. Candidal Onychomycosis
5.2.1.5. Total Dystrophic Onychomycosis
5.3. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, by Gender, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Male
5.3.1.2. Female
5.4. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. 0-18 Years
5.4.1.2. 18-39 Years
5.4.1.3. 40-64 Years
5.4.1.4. 65 Years and Above
5.5. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Institutional Sales
5.5.1.1.1. Hospitals
5.5.1.1.2. Dermatology Clinics
5.5.1.2. Retail Sales
5.5.1.2.1. Retail Pharmacies
5.5.1.2.2. Drug Stores
5.5.1.2.3. Mail Order Pharmacies & Online Sales
5.5.2. BPS Analysis/Market Attractiveness Analysis
5.6. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.6.1. Key Highlights
5.6.1.1. Germany Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
5.6.1.2. Germany Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.3. Germany Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
5.6.1.4. Germany Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
5.6.1.5. Germany Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.6. U.K. Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
5.6.1.7. U.K. Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.8. U.K. Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
5.6.1.9. U.K. Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
5.6.1.10. U.K. Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.11. France Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
5.6.1.12. France Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.13. France Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
5.6.1.14. France Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
5.6.1.15. France Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.16. Italy Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
5.6.1.17. Italy Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.18. Italy Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
5.6.1.19. Italy Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
5.6.1.20. Italy Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.21. Turkey Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
5.6.1.22. Turkey Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.23. Turkey Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
5.6.1.24. Turkey Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
5.6.1.25. Turkey Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.26. Russia Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
5.6.1.27. Russia Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.28. Russia Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
5.6.1.29. Russia Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
5.6.1.30. Russia Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.31. Rest of Europe Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
5.6.1.32. Rest of Europe Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.33. Rest of Europe Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
5.6.1.34. Rest of Europe Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
5.6.1.35. Rest of Europe Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, 2018 - 2031
6.1. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
6.1.1.1. Key Dermatophytic Onychomycosis Therapeutic Drugs
6.1.1.1.1. Oral
6.1.1.1.1.1. Rx
6.1.1.1.1.2. OTC
6.1.1.1.2. Topical
6.1.1.1.2.1. Rx
6.1.1.1.2.2. OTC
6.1.1.2. Dermatophytic Onychomycosis Therapeutic Lasers
6.1.1.2.1. C02 Ablative Lasers
6.1.1.2.2. Nd:YAG Lasers
6.1.2. Dual-wavelength near-infrared Lasers
6.2. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Distal Subungual Onychomycosis
6.2.1.2. White Superficial Onychomycosis
6.2.1.3. Proximal Subungual Onychomycosis
6.2.1.4. Candidal Onychomycosis
6.2.1.5. Total Dystrophic Onychomycosis
6.3. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, by Gender, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Male
6.3.1.2. Female
6.4. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. 0-18 Years
6.4.1.2. 18-39 Years
6.4.1.3. 40-64 Years
6.4.1.4. 65 Years and Above
6.5. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. Institutional Sales
6.5.1.1.1. Hospitals
6.5.1.1.2. Dermatology Clinics
6.5.1.2. Retail Sales
6.5.1.2.1. Retail Pharmacies
6.5.1.2.2. Drug Stores
6.5.1.2.3. Mail Order Pharmacies & Online Sales
6.5.2. BPS Analysis/Market Attractiveness Analysis
6.6. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.6.1. Key Highlights
6.6.1.1. China Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
6.6.1.2. China Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
6.6.1.3. China Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
6.6.1.4. China Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
6.6.1.5. China Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.6. Japan Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
6.6.1.7. Japan Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
6.6.1.8. Japan Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
6.6.1.9. Japan Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
6.6.1.10. Japan Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.11. South Korea Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
6.6.1.12. South Korea Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
6.6.1.13. South Korea Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
6.6.1.14. South Korea Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
6.6.1.15. South Korea Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.16. India Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
6.6.1.17. India Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
6.6.1.18. India Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
6.6.1.19. India Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
6.6.1.20. India Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.21. Southeast Asia Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
6.6.1.22. Southeast Asia Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
6.6.1.23. Southeast Asia Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
6.6.1.24. Southeast Asia Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
6.6.1.25. Southeast Asia Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.26. Rest of Asia Pacific Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
6.6.1.27. Rest of Asia Pacific Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
6.6.1.28. Rest of Asia Pacific Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
6.6.1.29. Rest of Asia Pacific Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
6.6.1.30. Rest of Asia Pacific Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, 2018 - 2031
7.1. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Dermatophytic Onychomycosis Therapeutic Drugs
7.1.1.1.1. Oral
7.1.1.1.1.1. Rx
7.1.1.1.1.2. OTC
7.1.1.1.2. Topical
7.1.1.1.2.1. Rx
7.1.1.1.2.2. OTC
7.1.1.2. Dermatophytic Onychomycosis Therapeutic Lasers
7.1.1.2.1. C02 Ablative Lasers
7.1.1.2.2. Nd:YAG Lasers
7.1.1.3. Dual-wavelength near-infrared Lasers
7.2. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
7.2.1.1. Distal Subungual Onychomycosis
7.2.1.2. White Superficial Onychomycosis
7.2.1.3. Proximal Subungual Onychomycosis
7.2.1.4. Candidal Onychomycosis
7.2.1.5. Total Dystrophic Onychomycosis
7.3. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Gender, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Male
7.3.1.2. Female
7.4. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. 0-18 Years
7.4.1.2. 18-39 Years
7.4.1.3. 40-64 Years
7.4.1.4. 65 Years and Above
7.5. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Institutional Sales
7.5.1.1.1. Hospitals
7.5.1.1.2. Dermatology Clinics
7.5.1.2. Retail Sales
7.5.1.2.1. Retail Pharmacies
7.5.1.2.2. Drug Stores
7.5.1.2.3. Mail Order Pharmacies & Online Sales
7.5.2. BPS Analysis/Market Attractiveness Analysis
7.6. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.6.1. Key Highlights
7.6.1.1. Brazil Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
7.6.1.2. Brazil Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
7.6.1.3. Brazil Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
7.6.1.4. Brazil Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
7.6.1.5. Brazil Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.6.1.6. Mexico Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
7.6.1.7. Mexico Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
7.6.1.8. Mexico Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
7.6.1.9. Mexico Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
7.6.1.10. Mexico Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.6.1.11. Argentina Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
7.6.1.12. Argentina Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
7.6.1.13. Argentina Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
7.6.1.14. Argentina Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
7.6.1.15. Argentina Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.6.1.16. Rest of Latin America Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
7.6.1.17. Rest of Latin America Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
7.6.1.18. Rest of Latin America Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
7.6.1.19. Rest of Latin America Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
7.6.1.20. Rest of Latin America Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.6.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, 2018 - 2031
8.1. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Dermatophytic Onychomycosis Therapeutic Drugs
8.1.1.1.1. Oral
8.1.1.1.1.1. Rx
8.1.1.1.1.2. OTC
8.1.1.1.2. Topical
8.1.1.1.2.1. Rx
8.1.1.1.2.2. OTC
8.1.1.2. Dermatophytic Onychomycosis Therapeutic Lasers
8.1.1.2.1. C02 Ablative Lasers
8.1.1.2.2. Nd:YAG Lasers
8.1.1.3. Dual-wavelength near-infrared Lasers
8.2. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Distal Subungual Onychomycosis
8.2.1.2. White Superficial Onychomycosis
8.2.1.3. Proximal Subungual Onychomycosis
8.2.1.4. Candidal Onychomycosis
8.2.1.5. Total Dystrophic Onychomycosis
8.3. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, by Gender, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Male
8.3.1.2. Female
8.4. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. 0-18 Years
8.4.1.2. 18-39 Years
8.4.1.3. 40-64 Years
8.4.1.4. 65 Years and Above
8.5. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. Institutional Sales
8.5.1.1.1. Hospitals
8.5.1.1.2. Dermatology Clinics
8.5.1.2. Retail Sales
8.5.1.2.1. Retail Pharmacies
8.5.1.2.2. Drug Stores
8.5.1.2.3. Mail Order Pharmacies & Online Sales
8.5.2. BPS Analysis/Market Attractiveness Analysis
8.6. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.6.1. Key Highlights
8.6.1.1. GCC Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
8.6.1.2. GCC Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
8.6.1.3. GCC Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
8.6.1.4. GCC Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
8.6.1.5. GCC Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.1.6. South Africa Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
8.6.1.7. South Africa Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
8.6.1.8. South Africa Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
8.6.1.9. South Africa Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
8.6.1.10. South Africa Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.1.11. Egypt Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
8.6.1.12. Egypt Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
8.6.1.13. Egypt Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
8.6.1.14. Egypt Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
8.6.1.15. Egypt Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.1.16. Nigeria Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
8.6.1.17. Nigeria Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
8.6.1.18. Nigeria Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
8.6.1.19. Nigeria Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
8.6.1.20. Nigeria Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.1.21. Rest of Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2018 - 2031
8.6.1.22. Rest of Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2018 - 2031
8.6.1.23. Rest of Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2018 - 2031
8.6.1.24. Rest of Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2018 - 2031
8.6.1.25. Rest of Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Indication Heatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Bausch Health
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Galderma S.A.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Novartis AG
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Pfizer, Inc.
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Moberg Pharma AB
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Bayer AG
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Dr. Reddy’s Laboratories Ltd.
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Cipla Ltd.
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Medimetriks Pharmaceuticals, Inc.
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Sanofi S.A.
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. GlaxoSmithKline Plc.
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Teva Pharmaceutical industries Ltd.
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations
